As a member of the Membership Committee of Band of Angels in California’s Silicon Valley, Brian Frenzel has decades of experience as a successful biomedical entrepreneur. Brian Frenzel currently heads the oncology drug research and development company Tosk, Inc. and serves on the Management Advisory Board of SanBio, Ltd., which is developing regenerative medicines for patients with neurodegenerative disorders such as stroke, traumatic brain injury, and Parkinson’s disease. Although researchers have yet to find a cure for Parkinson’s disease, a variety of treatment options exist. Physicians often recommend a regimen of exercise and physical therapy to help improve balance and mobility. In some cases, working with a speech-language pathologist can help treat speech impairments. Medications also may play an important role in treating Parkinson’s disease, especially in its later stages. One of the most common, levodopa, converts to dopamine in the brain, thereby improving mobility. Often, physicians prescribe carbidopa with levodopa to prevent the breakdown of levodopa before it enters the brain. Patients with extreme symptoms may want to consider surgery, such as deep brain stimulation (DBS), or cell therapy. In each case, physicians work with patients to treat individually manifesting symptoms.
0 Comments
|
AuthorAt Genelabs Technologies in the 1980’s, Brian Frenzel served on the front lines in the war on HIV/AIDS and championed projects to identify and diagnose new hepatitis viruses. Archives
June 2020
Categories
All
|